Literature DB >> 25882688

Hepatic radiofrequency ablation: in vivo and ex vivo comparisons of 15-gauge (G) and 17-G internally cooled electrodes.

K D Song1, M W Lee, H J Park, D I Cha, T W Kang, J Lee, J Y Moon, H Rhim.   

Abstract

OBJECTIVE: To compare the performance of the 15-G internally cooled electrode with that of the conventional 17-G internally cooled electrode.
METHODS: A total of 40 (20 for each electrode) and 20 ablation zones (10 for each electrode) were made in extracted bovine livers and in in vivo porcine livers, respectively. Technical parameters, three dimensions [long-axis diameter (Dl), vertical-axis diameter (Dv) and short-axis diameter (Ds)], volume and the circularity (Ds/Dl) of the ablation zone were compared.
RESULTS: The total delivered energy was higher in the 15-G group than in the 17-G group in both ex vivo and in vivo studies (8.78 ± 1.06 vs 7.70 ± 0.98 kcal, p = 0.033; 11.20 ± 1.13 vs 8.49 ± 0.35 kcal, p = 0.001, respectively). The three dimensions of the ablation zone had a tendency to be larger in the 15-G group than in the 17-G group in both studies. The ablation volume was larger in the 15-G group than in the 17-G group in both ex vivo and in vivo studies (29.61 ± 7.10 vs 23.86 ± 3.82 cm(3), p = 0.015; 10.26 ± 2.28 vs 7.79 ± 1.68 cm(3), p = 0.028, respectively). The circularity of ablation zone was not significantly different in both the studies.
CONCLUSION: The size of ablation zone was larger in the 15-G internally cooled electrode than in the 17-G electrode in both ex vivo and in vivo studies. ADVANCES IN KNOWLEDGE: Radiofrequency ablation of hepatic tumours using 15-G electrode is useful to create larger ablation zones.

Entities:  

Mesh:

Year:  2015        PMID: 25882688      PMCID: PMC4628443          DOI: 10.1259/bjr.20140497

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  24 in total

1.  A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria.

Authors:  Jiwei Huang; Lvnan Yan; Zheyu Cheng; Hong Wu; Liang Du; Jinzhou Wang; Yinglong Xu; Yong Zeng
Journal:  Ann Surg       Date:  2010-12       Impact factor: 12.969

2.  Switching monopolar radiofrequency ablation technique using multiple, internally cooled electrodes and a multichannel generator: ex vivo and in vivo pilot study.

Authors:  Jeong Min Lee; Joon Koo Han; Hyo Cheol Kim; Young Hun Choi; Se Hyung Kim; Jin Young Choi; Byung Ihn Choi
Journal:  Invest Radiol       Date:  2007-03       Impact factor: 6.016

3.  Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization.

Authors:  Manabu Morimoto; Kazushi Numata; Masaaki Kondou; Akito Nozaki; Satoshi Morita; Katsuaki Tanaka
Journal:  Cancer       Date:  2010-07-29       Impact factor: 6.860

4.  A comparison of US-guided percutaneous radiofrequency ablation of medium-sized hepatocellular carcinoma with a cluster electrode or a single electrode with a multiple overlapping ablation technique.

Authors:  Min Jung Park; Young-sun Kim; Hyunchul Rhim; Hyo Keun Lim; Min Woo Lee; Dongil Choi
Journal:  J Vasc Interv Radiol       Date:  2011-06       Impact factor: 3.464

5.  Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone.

Authors:  Jin Hyoung Kim; Hyung Jin Won; Yong Moon Shin; Sung Hee Kim; Hyun-Ki Yoon; Kyu-Bo Sung; Pyo Nyun Kim
Journal:  Ann Surg Oncol       Date:  2011-03-29       Impact factor: 5.344

6.  A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

Authors:  Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Shinpei Sato; Ryosuke Tateishi; Tomonori Fujishima; Takashi Ishikawa; Yukihiro Koike; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

Review 7.  Microwave tumor ablation: mechanism of action, clinical results, and devices.

Authors:  Meghan G Lubner; Christopher L Brace; J Louis Hinshaw; Fred T Lee
Journal:  J Vasc Interv Radiol       Date:  2010-08       Impact factor: 3.464

8.  Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size.

Authors:  S N Goldberg; G S Gazelle; E F Halpern; W J Rittman; P R Mueller; D I Rosenthal
Journal:  Acad Radiol       Date:  1996-03       Impact factor: 3.173

9.  Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression.

Authors:  Haruyuki Takaki; Koichiro Yamakado; Atsuhiro Nakatsuka; Hiroyuki Fuke; Kazumoto Murata; Katsuya Shiraki; Kan Takeda
Journal:  J Vasc Interv Radiol       Date:  2007-07       Impact factor: 3.464

10.  Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.

Authors:  Shuichiro Shiina; Ryosuke Tateishi; Toru Arano; Koji Uchino; Kenichiro Enooku; Hayato Nakagawa; Yoshinari Asaoka; Takahisa Sato; Ryota Masuzaki; Yuji Kondo; Tadashi Goto; Haruhiko Yoshida; Masao Omata; Kazuhiko Koike
Journal:  Am J Gastroenterol       Date:  2011-12-13       Impact factor: 10.864

View more
  2 in total

1.  Pennes' bioheat equation vs. porous media approach in computer modeling of radiofrequency tumor ablation.

Authors:  Claudio Tucci; Macarena Trujillo; Enrique Berjano; Marcello Iasiello; Assunta Andreozzi; Giuseppe Peter Vanoli
Journal:  Sci Rep       Date:  2021-03-05       Impact factor: 4.379

2.  How large is the periablational zone after radiofrequency and microwave ablation? Computer-based comparative study of two currently used clinical devices.

Authors:  Macarena Trujillo; Punit Prakash; Pegah Faridi; Aleksandar Radosevic; Sergio Curto; Fernando Burdio; Enrique Berjano
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.